Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ATP synthase (F₁F₀-ATP synthase) is the core enzyme responsible for ATP production in mycobacteria by utilizing the proton motive force (PMF) generated through the electron transport chain (ETC) during oxidative phosphorylation[1][3][8]. Key ETC components include NADH dehydrogenases (NDH-1, NDH-2), succinate dehydrogenase (SDH), menaquinone, cytochrome complexes, and fumarate reductase, supporting aerobic and anaerobic energy metabolism[1][3][7]. Mycobacteria are remarkable for their metabolic flexibility, especially adaptation to hypoxia and nutrient shifts, mediated via complex regulatory networks and metabolic remodeling[2][7]. Drugs such as bedaquiline and Q203 selectively inhibit mycobacterial energy metabolism, making ATP synthase and ETC enzymes prime targets for tuberculosis therapy[1][8]. In summary, "Mycobacterial energy production" should be mapped to specific molecular targets (primarily ATP synthase and select electron transport chain enzymes) for therapeutic and scientific purposes[1][8][3].
Inhibition of ATP synthase (inhibiting conversion of PMF to ATP by bedaquiline) Disruption of electron transport chain (Q203 inhibition of cytochrome bc₁, thioridazine, phenothiazines block NDH-2, SDH) Dissipation of proton motive force (by ionophores, some antibiotics) Depletion of ATP pool
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP synthase (F₁F₀-ATP synthase) (ATP synthase).